238 related articles for article (PubMed ID: 32779106)
1. What factors have impact on glucocorticoid replacement in adrenal insufficiency: a real-life study.
Puglisi S; Rossini A; Tabaro I; Cannavò S; Ferrau' F; Ragonese M; Borretta G; Pellegrino M; Dughera F; Parisi A; Latina A; Pia A; Terzolo M; Reimondo G
J Endocrinol Invest; 2021 Apr; 44(4):865-872. PubMed ID: 32779106
[TBL] [Abstract][Full Text] [Related]
2. Current Management and Outcome of Pregnancies in Women With Adrenal Insufficiency: Experience from a Multicenter Survey.
Bothou C; Anand G; Li D; Kienitz T; Seejore K; Simeoli C; Ebbehoj A; Ward EG; Paragliola RM; Ferrigno R; Badenhoop K; Bensing S; Oksnes M; Esposito D; Bergthorsdottir R; Drake W; Wahlberg J; Reisch N; Hahner S; Pearce S; Trainer P; Etzrodt-Walter G; Thalmann SP; Sævik ÅB; Husebye E; Isidori AM; Falhammar H; Meyer G; Corsello SM; Pivonello R; Murray R; Bancos I; Quinkler M; Beuschlein F
J Clin Endocrinol Metab; 2020 Aug; 105(8):e2853-63. PubMed ID: 32424397
[TBL] [Abstract][Full Text] [Related]
3. Cardiometabolic and psychological effects of dual-release hydrocortisone: a cross-over study.
Dineen R; Martin-Grace J; Ahmed KMS; Frizelle I; Gunness A; Garrahy A; Hannon AM; O'Reilly MW; Smith D; McDermott J; Healy ML; Agha A; Pazderska A; Gibney J; Thompson CJ; Behan LA; Sherlock M
Eur J Endocrinol; 2021 Feb; 184(2):253-265. PubMed ID: 33513125
[TBL] [Abstract][Full Text] [Related]
4. An observational study on adrenal insufficiency in a French tertiary centre: Real life versus theory.
Castinetti F; Sahnoun M; Albarel F; Morange I; Philippon M; Conte-Devolx B; Brue T
Ann Endocrinol (Paris); 2015 Feb; 76(1):1-8. PubMed ID: 25617904
[TBL] [Abstract][Full Text] [Related]
5. Impaired attention in patients with adrenal insufficiency - Impact of unphysiological therapy.
Blacha AK; Rahvar AH; Flitsch J; van de Loo I; Kropp P; Harbeck B
Steroids; 2021 Mar; 167():108788. PubMed ID: 33412217
[TBL] [Abstract][Full Text] [Related]
6. Towards the tailoring of glucocorticoid replacement in adrenal insufficiency: the Italian Society of Endocrinology Expert Opinion.
Isidori AM; Arnaldi G; Boscaro M; Falorni A; Giordano C; Giordano R; Pivonello R; Pozza C; Sbardella E; Simeoli C; Scaroni C; Lenzi A;
J Endocrinol Invest; 2020 May; 43(5):683-696. PubMed ID: 31773582
[TBL] [Abstract][Full Text] [Related]
7. Daily adjustment of glucocorticoids by patients with adrenal insufficiency.
Schöfl C; Mayr B; Maison N; Beuschlein F; Meyer G; Badenhoop K; Kienitz T; Quinkler M
Clin Endocrinol (Oxf); 2019 Aug; 91(2):256-262. PubMed ID: 31050815
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of adrenal deficiency: To what issues? By which therapeutic means?].
Reznik Y
Presse Med; 2014 Apr; 43(4 Pt 1):438-43. PubMed ID: 24636680
[TBL] [Abstract][Full Text] [Related]
9. GLUCOCORTICOID REPLACEMENT REGIMENS IN CHRONIC ADRENAL INSUFFICIENCY: A SYSTEMATIC REVIEW AND META-ANALYSIS.
Al Nofal A; Bancos I; Benkhadra K; Ospina NM; Javed A; Kapoor E; Muthusamy K; Brito JP; Turcu AF; Wang Z; Prokop L; Erickson DZ; Lteif AN; Natt N; Murad MH
Endocr Pract; 2017 Jan; 23(1):17-31. PubMed ID: 27631672
[TBL] [Abstract][Full Text] [Related]
10. Usefulness of Time-Point Serum Cortisol and ACTH Measurements for the Adjustment of Glucocorticoid Replacement in Adrenal Insufficiency.
Rousseau E; Joubert M; Trzepla G; Parienti JJ; Freret T; Vanthygem MC; Desailloud R; Lefebvre H; Coquerel A; Reznik Y;
PLoS One; 2015; 10(8):e0135975. PubMed ID: 26317782
[TBL] [Abstract][Full Text] [Related]
11. Daily Glucocorticoid Replacement Dose in Adrenal Insufficiency, a Mini Review.
Caetano CM; Malchoff CD
Front Endocrinol (Lausanne); 2022; 13():897211. PubMed ID: 35846313
[TBL] [Abstract][Full Text] [Related]
12. Effects of Dual-Release Hydrocortisone on Bone Metabolism in Primary and Secondary Adrenal Insufficiency: A 6-Year Study.
Hasenmajer V; Ferrari D; De Alcubierre D; Sada V; Puliani G; Bonaventura I; Minnetti M; Tomaselli A; Pofi R; Sbardella E; Cozzolino A; Gianfrilli D; Isidori AM
J Endocr Soc; 2023 Dec; 8(1):bvad151. PubMed ID: 38090230
[TBL] [Abstract][Full Text] [Related]
13. Somatosensory function in patients with secondary adrenal insufficiency treated with two different doses of hydrocortisone-Results from a randomized controlled trial.
Werumeus Buning J; Konopka KH; Brummelman P; Koerts J; Dullaart RPF; van den Berg G; van der Klauw MM; Tucha O; Wolffenbuttel BHR; van Beek AP
PLoS One; 2017; 12(7):e0180326. PubMed ID: 28686664
[TBL] [Abstract][Full Text] [Related]
14. Effects of standard glucocorticoid replacement therapies on subjective well-being: a randomized, double-blind, crossover study in patients with secondary adrenal insufficiency.
Benson S; Neumann P; Unger N; Schedlowski M; Mann K; Elsenbruch S; Petersenn S
Eur J Endocrinol; 2012 Nov; 167(5):679-85. PubMed ID: 22930487
[TBL] [Abstract][Full Text] [Related]
15. Management of glucocorticoid replacement in adrenal insufficiency shows notable heterogeneity - data from the EU-AIR.
Murray RD; Ekman B; Uddin S; Marelli C; Quinkler M; Zelissen PM;
Clin Endocrinol (Oxf); 2017 Mar; 86(3):340-346. PubMed ID: 27801983
[TBL] [Abstract][Full Text] [Related]
16. Effects of the therapy shift from cortisone acetate to modified-release hydrocortisone in a group of patients with adrenal insufficiency.
Frigerio S; Carosi G; Ferrante E; Sala E; Polledri E; Fustinoni S; Ambrosi B; Chiodini I; Mantovani G; Morelli V; Arosio M
Front Endocrinol (Lausanne); 2023; 14():1093838. PubMed ID: 36761196
[TBL] [Abstract][Full Text] [Related]
17. [CME: Adrenal Insufficiency].
Fischli S
Praxis (Bern 1994); 2018 Jun; 107(13):717-725. PubMed ID: 29921185
[TBL] [Abstract][Full Text] [Related]
18. Glucocorticoid Replacement Affects Serum Adiponectin Levels and HDL-C in Patients With Secondary Adrenal Insufficiency.
Hayashi R; Tamada D; Murata M; Kitamura T; Mukai K; Maeda N; Otsuki M; Shimomura I
J Clin Endocrinol Metab; 2019 Dec; 104(12):5814-5822. PubMed ID: 31290981
[TBL] [Abstract][Full Text] [Related]
19. Consensus statement on the diagnosis, treatment and follow-up of patients with primary adrenal insufficiency.
Husebye ES; Allolio B; Arlt W; Badenhoop K; Bensing S; Betterle C; Falorni A; Gan EH; Hulting AL; Kasperlik-Zaluska A; Kämpe O; Løvås K; Meyer G; Pearce SH
J Intern Med; 2014 Feb; 275(2):104-15. PubMed ID: 24330030
[TBL] [Abstract][Full Text] [Related]
20. Benefits of dual-release hydrocortisone treatment on central adiposity and health-related quality of life in secondary adrenal insufficiency.
Gasco V; Giannelli J; Campioni L; Arvat E; Ghigo E; Grottoli S; Maccario M; Giordano R
J Endocrinol Invest; 2023 Mar; 46(3):587-597. PubMed ID: 36251244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
